Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 13
2003 10
2004 13
2005 13
2006 12
2007 10
2008 22
2009 23
2010 32
2011 23
2012 12
2013 7
2014 13
2015 8
2016 12
2017 8
2018 7
2019 10
2020 7
2021 7
2022 11
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive genetic map of cytokine responses in Lyme borreliosis.
Botey-Bataller J, Vrijmoeth HD, Ursinus J, Kullberg BJ, van den Wijngaard CC, Ter Hofstede H, Alaswad A, Gupta MK, Roesner LM, Huehn J, Werfel T, Schulz TF, Xu CJ, Netea MG, Hovius JW, Joosten LAB, Li Y. Botey-Bataller J, et al. Among authors: kullberg bj. Nat Commun. 2024 May 7;15(1):3795. doi: 10.1038/s41467-024-47505-z. Nat Commun. 2024. PMID: 38714679 Free PMC article.
Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications.
Vrijmoeth HD, Ursinus J, Botey-Bataller J, Kuijpers Y, Chu X, van de Schoor FR, Scicluna BP, Xu CJ, Netea MG, Kullberg BJ, van den Wijngaard CC, Li Y, Hovius JW, Joosten LAB. Vrijmoeth HD, et al. Among authors: kullberg bj. BMC Infect Dis. 2024 Mar 21;24(1):337. doi: 10.1186/s12879-024-09217-z. BMC Infect Dis. 2024. PMID: 38515037 Free PMC article.
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
Vrijmoeth HD, Ursinus J, Harms MG, Tulen AD, Baarsma ME, van de Schoor FR, Gauw SA, Zomer TP, Vermeeren YM, Ferreira JA, Sprong H, Kremer K, Knoop H, Joosten LAB, Kullberg BJ, Hovius JW, van den Wijngaard CC. Vrijmoeth HD, et al. Among authors: kullberg bj. EBioMedicine. 2023 Dec;98:104825. doi: 10.1016/j.ebiom.2023.104825. Epub 2023 Nov 27. EBioMedicine. 2023. PMID: 38016860 Free PMC article.
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials.
Thompson GR 3rd, Soriano A, Honore PM, Bassetti M, Cornely OA, Kollef M, Kullberg BJ, Pullman J, Hites M, Fortún J, Horcajada JP, Kotanidou A, Das AF, Sandison T, Aram JA, Vazquez JA, Pappas PG. Thompson GR 3rd, et al. Among authors: kullberg bj. Lancet Infect Dis. 2024 Mar;24(3):319-328. doi: 10.1016/S1473-3099(23)00551-0. Epub 2023 Nov 23. Lancet Infect Dis. 2024. PMID: 38008099 Free article. Clinical Trial.
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
Ursinus J, Vrijmoeth HD, Harms MG, Tulen AD, Knoop H, Gauw SA, Zomer TP, Wong A, Friesema IHM, Vermeeren YM, Joosten LAB, Hovius JW, Kullberg BJ, van den Wijngaard CC. Ursinus J, et al. Among authors: kullberg bj. Lancet Reg Health Eur. 2023 Mar 15;27:100622. doi: 10.1016/j.lanepe.2023.100622. eCollection 2023 Apr. Lancet Reg Health Eur. 2023. PMID: 36968322 Free PMC article.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Thompson GR 3rd, et al. Among authors: kullberg bj. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442484 Free article. Clinical Trial.
Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.
Kerstholt M, van de Schoor FR, Oosting M, Moorlag SJCFM, Li Y, Jaeger M, van der Heijden WA, Tunjungputri RN, Dos Santos JC, Kischkel B, Vrijmoeth HD, Baarsma ME, Kullberg BJ, Lupse M, Hovius JW, van den Wijngaard CC, Netea MG, de Mast Q, Joosten LAB. Kerstholt M, et al. Among authors: kullberg bj. Clin Exp Immunol. 2022 Oct 21;210(1):53-67. doi: 10.1093/cei/uxac073. Clin Exp Immunol. 2022. PMID: 36001729 Free PMC article.
Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.
Baarsma ME, van de Schoor FR, Gauw SA, Vrijmoeth HD, Ursinus J, Goudriaan N, Popa CD, Ter Hofstede HJ, Leeflang MM, Kremer K, van den Wijngaard CC, Kullberg BJ, Joosten LA, Hovius JW. Baarsma ME, et al. Among authors: kullberg bj. Lancet Infect Dis. 2022 Sep;22(9):1388-1396. doi: 10.1016/S1473-3099(22)00205-5. Epub 2022 Jun 14. Lancet Infect Dis. 2022. PMID: 35714662
256 results